Arias-Moliz MT, Rojas L, LiŽbana-Cabanillas F, Bernal C, Castillo F, Rodr’guez- Archilla A,  Castillo A, LiŽbana J. Serologic control against hepatitis B virus among dental students of the University of Granada, Spain. Med Oral Patol Oral Cir Bucal. 2015 Sep 1;20 (5):e566-71.

 

 

doi:10.4317/medoral.20579

http://dx.doi.org/doi:10.4317/medoral.20579

 

 

1. World Health Organization. Hepatitis B vaccines WHO position paper. Weekly Epidemiological Record (WER). 2009;84:405-20.

 

2. Chaves SS, Fischer G, Groeger J, Patel PR, Thompson ND, Teshale EH, et al. Persistence of long-term immunity to hepatitis B among adolescents immunized at birth. Vaccine. 2012;30:1644-9.
http://dx.doi.org/10.1016/j.vaccine.2011.12.106

 

3. Honorati MC, Palareti A, Dolzani P, Busachi CA, Rizzoli R, Facchini A. A mathematical model predicting antihepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B. Clin Exp Immunol. 1999;116:121-6.
http://dx.doi.org/10.1046/j.1365-2249.1999.00866.x

 

4. Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011;53:68-75.
http://dx.doi.org/10.1093/cid/cir270

 

5. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60:1-45.

 

6. Petti S, Messano GA, Polimeni A. Dentists' awareness toward vaccine preventable diseases. Vaccine. 2011;29:8108-12.
http://dx.doi.org/10.1016/j.vaccine.2011.08.034

 

7. Yang SG, Wang B, Chen P, Yu CB, Deng M, Yao J, et al. Effectiveness of HBV vaccination in infants and prediction of HBV prevalence trend under new vaccination plan: findings of a large-scale investigation. PLoS One. 2012;7:e47808.
http://dx.doi.org/10.1371/journal.pone.0047808

 

8. Boot HJ, van der Waaij LA, Schirm J, Kallenberg CG, van Steenbergen J, Wolters B. Acute hepatitis B in a healthcare worker: a case report of genuine vaccination failure. J Hepatol. 2009;50:426-31.
http://dx.doi.org/10.1016/j.jhep.2008.07.040

 

9. Fitzsimons D, Franois G, Hall A, McMahon B, Meheus A, Zanetti A, et al. Long-term efficacy of hepatitis B vaccine, booster policy and impact of hepatitis B virus mutants. Vaccine. 2005;23:4158-66.
http://dx.doi.org/10.1016/j.vaccine.2005.03.017

 

10. Duval B, G”lca V, Boulianne N, De Wals P, MassŽ R, Trudeau G, et al. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country. Pediatr Infect Dis J. 2005;24:213-8.
http://dx.doi.org/10.1097/01.inf.0000154329.00361.39

 

11. Gilca V, De Serres G, Boulianne N, Murphy D, De Wals P, Ouakki M, et al. Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine. Vaccine. 2013;31:448-51.
http://dx.doi.org/10.1016/j.vaccine.2012.11.037

 

12. Zanetti AR, Tanzi E, Pozzi A, Romano L, Bergamini F. Yeast-derived hepatitis B vaccine in dental students. A three-year follow-up study. Vaccine. 1990;8:205-8.
http://dx.doi.org/10.1016/0264-410X(90)90046-O

 

13. Centers for Disease Control and Prevention (CDC). Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). Morbidity and Mortality Weekly Report. 1997;46:1-42.

 

14. Lindley MC, Lorick SA, Spinner JR, Krull AR, Mootrey GT, Ahmed F, et al. Student vaccination requirements of U.S. health professional schools: a survey. Ann Intern Med. 2011;154:391-400.
http://dx.doi.org/10.7326/0003-4819-154-6-201103150-00004

 

15. Spradling PR, Williams RE, Xing J, Soyemi K, Towers J. Serologic testing for protection against hepatitis B virus infection among students at a health sciences university in the United States. Infect Control Hosp Epidemiol. 2012;33:732-6.
http://dx.doi.org/10.1086/666335

 

16. van Wijk PT, Meiberg AE, Bruers JJ, Groenewold MH, van Raalten AL, Dam BA, et al. The risk of blood exposure incidents in dental practices in the Netherlands. Community Dent Oral Epidemiol. 2012;40:567-73.
http://dx.doi.org/10.1111/j.1600-0528.2012.00702.x

 

17. Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med. 1998;15:1-8.
http://dx.doi.org/10.1016/S0749-3797(98)00003-8

 

18. Shaw FE, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ, et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine. 1989;7:425-30.
http://dx.doi.org/10.1016/0264-410X(89)90157-6

 

19. Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA. 1985;254:3187-9.
http://dx.doi.org/10.1001/jama.1985.03360220053027

 

20. Hennig BJ, Fielding K, Broxholme J, Diatta M, Mendy M, Moore C, et al. Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. PLoS One. 2008;3:e1898.

 

21. Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz AJ, Brink SJ, et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med. 1989;321:708-12.
http://dx.doi.org/10.1056/NEJM198909143211103

 

22. Craven DE, Awdeh ZL, Kunches LM, Yunis EJ, Dienstag JL, Werner BG, et al. Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med. 1986;105:356-60.
http://dx.doi.org/10.7326/0003-4819-105-3-356

 

23. Are booster immunisations needed for lifelong hepatitis B immunity. European Consensus Group on Hepatitis B Immunity. Lancet. 2000;355:561-5.
http://dx.doi.org/10.1016/S0140-6736(99)07239-6

 

24. Aypak C, YŸce A, Yőkőlkan H, Gšrpelioğlu S. Persistence of protection of hepatitis B vaccine and response to booster immunization in 2- to 12-year-old children. Eur J Pediatr. 2012;171:1761-6.
http://dx.doi.org/10.1007/s00431-012-1815-4

 

25. Petersen KM, Bulkow LR, McMahon BJ, Zanis C, Getty M, Peters H, et al. Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J. 2004;23:650-5.
http://dx.doi.org/10.1097/01.inf.0000130952.96259.fd

 

26. Tohme RA, Ribner B, Huey MJ, Spradling PR. Hepatitis B vaccination coverage and documented seroprotection among matriculating healthcare students at an academic institution in the United States. Infect Control Hosp Epidemiol. 2011;32:818-21.
http://dx.doi.org/10.1086/661102

 

27. Gilca V, De Serres G, Boulianne N, De Wals P, Murphy D, Trudeau G, et al. Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine. Hum Vaccine. 2010;6:212-8.
http://dx.doi.org/10.4161/hv.6.2.10299

 

28. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Bock HL, Leyssen M, Jacquet JM. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. Vaccine. 2010;28:730-6.
http://dx.doi.org/10.1016/j.vaccine.2009.10.074

 

29. Tele SA, Martins RM, Lopes CL, dos Santos MA, Souza KP, Yoshida CF. Immunogenicity of a recombinant hepatitis B vaccine (Euvax-B) in haemodialysis patients and staff. Eur J Epidemiol. 2001;17:145-9.
http://dx.doi.org/10.1023/A:1017918218784

 

30. Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine. 2007;25:6958-64.
http://dx.doi.org/10.1016/j.vaccine.2007.06.059